Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $635.63 million. The enterprise value is -$36.63 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 40.62 million shares outstanding. The number of shares has increased by 21.79% in one year.
| Current Share Class | 40.62M |
| Shares Outstanding | 40.62M |
| Shares Change (YoY) | +21.79% |
| Shares Change (QoQ) | -1.00% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 72.25% |
| Float | 28.06M |
Valuation Ratios
The trailing PE ratio is 33.63.
| PE Ratio | 33.63 |
| Forward PE | n/a |
| PS Ratio | 2.67 |
| Forward PS | n/a |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | 11.97 |
| P/OCF Ratio | 11.55 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.11, with a Debt / Equity ratio of 0.03.
| Current Ratio | 21.11 |
| Quick Ratio | 20.40 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 2.51 |
| Debt / FCF | 0.34 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.33% and return on invested capital (ROIC) is 0.03%.
| Return on Equity (ROE) | 3.33% |
| Return on Assets (ROA) | 0.03% |
| Return on Invested Capital (ROIC) | 0.03% |
| Return on Capital Employed (ROCE) | 0.04% |
| Revenue Per Employee | $1.38M |
| Profits Per Employee | $111,083 |
| Employee Count | 169 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KROS has paid $8.12 million in taxes.
| Income Tax | 8.12M |
| Effective Tax Rate | 30.20% |
Stock Price Statistics
The stock price has decreased by -74.23% in the last 52 weeks. The beta is 0.97, so KROS's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -74.23% |
| 50-Day Moving Average | 15.12 |
| 200-Day Moving Average | 13.54 |
| Relative Strength Index (RSI) | 52.20 |
| Average Volume (20 Days) | 370,572 |
Short Selling Information
The latest short interest is 4.62 million, so 11.37% of the outstanding shares have been sold short.
| Short Interest | 4.62M |
| Short Previous Month | 4.50M |
| Short % of Shares Out | 11.37% |
| Short % of Float | 16.46% |
| Short Ratio (days to cover) | 10.64 |
Income Statement
In the last 12 months, KROS had revenue of $232.84 million and earned $18.77 million in profits. Earnings per share was $0.47.
| Revenue | 232.84M |
| Gross Profit | 219.41M |
| Operating Income | 312,000 |
| Pretax Income | 26.89M |
| Net Income | 18.77M |
| EBITDA | 1.67M |
| EBIT | 312,000 |
| Earnings Per Share (EPS) | $0.47 |
Full Income StatementBalance Sheet
The company has $690.22 million in cash and $17.95 million in debt, giving a net cash position of $672.26 million or $16.55 per share.
| Cash & Cash Equivalents | 690.22M |
| Total Debt | 17.95M |
| Net Cash | 672.26M |
| Net Cash Per Share | $16.55 |
| Equity (Book Value) | 706.73M |
| Book Value Per Share | 17.40 |
| Working Capital | 698.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $55.04 million and capital expenditures -$1.96 million, giving a free cash flow of $53.08 million.
| Operating Cash Flow | 55.04M |
| Capital Expenditures | -1.96M |
| Free Cash Flow | 53.08M |
| FCF Per Share | $1.31 |
Full Cash Flow StatementMargins
Gross margin is 94.23%, with operating and profit margins of 0.13% and 8.06%.
| Gross Margin | 94.23% |
| Operating Margin | 0.13% |
| Pretax Margin | 11.55% |
| Profit Margin | 8.06% |
| EBITDA Margin | 0.72% |
| EBIT Margin | 0.13% |
| FCF Margin | 22.80% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.79% |
| Shareholder Yield | -21.79% |
| Earnings Yield | 2.95% |
| FCF Yield | 8.35% |
Dividend DetailsAnalyst Forecast
The average price target for KROS is $20.56, which is 31.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.56 |
| Price Target Difference | 31.37% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 95.50% |
| EPS Growth Forecast (5Y) | -17.99% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 15.29 and a Piotroski F-Score of 7.
| Altman Z-Score | 15.29 |
| Piotroski F-Score | 7 |
